Ask AI

Decoding Dual Action: Understanding Muscarinic Acetylcholine Receptors in Schizophrenia Management

Emerging research is reshaping schizophrenia care, offering pathways to address persistent symptoms while mitigating adverse events tied to traditional therapies. Interactive case discussions and clinical trial updates highlight new strategies to individualize treatment, improve adherence, and reduce psychosocial burdens for patients navigating the challenges of schizophrenia.

Share

Program Content

Activities

Schizophrenia Care Management DL
Dopamine Detours: New Paths for Positive, Negative & Cognitive Symptoms
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: December 09, 2025

Activities

Muscarinic Path in Schizophrenia
Dopamine Detours: New Paths for Positive, Negative & Cognitive Symptoms
Video
Congratulations: You achieved a completion on 04/09/2022

Released: December 30, 2025

Expires: December 29, 2026

Activities

Muscarinic Agonists in Schizophrenia
The Muscarinic Revolution: A Novel Treatment Paradigm for Schizophrenia
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: December 18, 2025

Activities

Muscarinic in Schizophrenia PC
Beyond the Podium: Continuing the Q&A on Schizophrenia
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: January 13, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education

Supporters

Supported by an educational grant from Bristol Myers Squibb. 

Bristol Myers Squibb